{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:04:47Z","timestamp":1790805887640,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jfma.2025.05.040","type":"journal-article","created":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T15:03:56Z","timestamp":1748876636000},"page":"574-583","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Cardiovascular outcomes of febuxostat and allopurinol: A long-term Taiwanese nationwide cohort study"],"prefix":"10.1016","volume":"125","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2073-3407","authenticated-orcid":false,"given":"Tsung-Lin","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin-Bang","family":"Leu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shing-Jong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2121-1910","authenticated-orcid":false,"given":"Jiun-Lin","family":"Horng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Ming","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfma.2025.05.040_bib1","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/nrrheum.2015.91","article-title":"Global epidemiology of gout: prevalence, incidence and risk factors","volume":"11","author":"Kuo","year":"2015","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jfma.2025.05.040_bib2","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1016\/S0140-6736(16)00346-9","volume":"388","author":"Dalbeth","year":"2016","journal-title":"Gout. Lancet"},{"key":"10.1016\/j.jfma.2025.05.040_bib3","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41572-019-0115-y","volume":"5","author":"Dalbeth","year":"2019","journal-title":"Gout. Nat Rev Dis Primers"},{"key":"10.1016\/j.jfma.2025.05.040_bib4","doi-asserted-by":"crossref","first-page":"ITC1","DOI":"10.7326\/AITC201607050","volume":"165","author":"Neogi","year":"2016","journal-title":"Gout. Ann Intern Med"},{"key":"10.1016\/j.jfma.2025.05.040_bib5","first-page":"1045","article-title":"Community based epidemiological study on hyperuricemia and gout in Kin-Hu, Kinmen","volume":"27","author":"Lin","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jfma.2025.05.040_bib6","first-page":"597","article-title":"Community-based epidemiological study on hyperuricemia in Pu-Li, Taiwan","volume":"92","author":"Chou","year":"1993","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jfma.2025.05.040_bib7","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1001\/jamacardio.2019.3201","article-title":"Dual-energy computed tomography detection of cardiovascular Monosodium urate deposits in patients with gout","volume":"4","author":"Klauser","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jfma.2025.05.040_bib8","first-page":"894","article-title":"Independent impact of gout on mortality and risk for coronary heart disease","volume":"116","author":"Choi","year":"2007","journal-title":"Circulation (New York, N Y)"},{"key":"10.1016\/j.jfma.2025.05.040_bib9","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/art.41247","article-title":"American College of Rheumatology guideline for the management of gout","volume":"72","author":"FitzGerald","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jfma.2025.05.040_bib10","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s41584-018-0149-7","article-title":"Prevention and treatment of gout","volume":"15","author":"Stamp","year":"2019","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jfma.2025.05.040_bib11","doi-asserted-by":"crossref","first-page":"i20","DOI":"10.1093\/rheumatology\/kex442","article-title":"Treat to target in gout","volume":"57","author":"Perez-Ruiz","year":"2018","journal-title":"Rheumatology (Oxf)"},{"key":"10.1016\/j.jfma.2025.05.040_bib12","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/BOR.0000000000000031","article-title":"Safety profile of anti-gout agents: an update","volume":"26","author":"Stamp","year":"2014","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.jfma.2025.05.040_bib13","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1001\/jama.2020.25473","article-title":"Race and pharmacogenomics-personalized medicine or misguided practice?","volume":"325","author":"Goodman","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.jfma.2025.05.040_bib14","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1001\/jamainternmed.2018.3556","article-title":"HLA-B\u22175801 testing to prevent allopurinol hypersensitivity syndrome: a teachable moment","volume":"178","author":"Quach","year":"2018","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jfma.2025.05.040_bib15","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1074\/jbc.M208307200","article-title":"An extremely potent inhibitor of xanthine oxidoreductase. Crystal structure of the enzyme-inhibitor complex and mechanism of inhibition","volume":"278","author":"Okamoto","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jfma.2025.05.040_bib16","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/art.20935","article-title":"Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase: a twenty-eight-day, multicenter, phase II, randomized, double-blind, placebo-controlled, dose-response clinical trial examining safety and efficacy in patients with gout","volume":"52","author":"Becker","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jfma.2025.05.040_bib17","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/0006-291X(87)91112-0","article-title":"Role of xanthine oxidase inhibitor as free radical scavenger: a novel mechanism of action of allopurinol and oxypurinol in myocardial salvage","volume":"148","author":"Das","year":"1987","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jfma.2025.05.040_bib18","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1056\/NEJMoa050373","article-title":"Febuxostat compared with allopurinol in patients with hyperuricemia and gout","volume":"353","author":"Becker","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfma.2025.05.040_bib19","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/art.24209","article-title":"Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial","volume":"59","author":"Schumacher","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jfma.2025.05.040_bib20","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.3899\/jrheum.080814","article-title":"Clinical efficacy and safety of successful longterm urate lowering with febuxostat or allopurinol in subjects with gout","volume":"36","author":"Becker","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jfma.2025.05.040_bib21","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1056\/NEJMoa1710895","article-title":"Cardiovascular safety of febuxostat or allopurinol in patients with gout","volume":"378","author":"White","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfma.2025.05.040_bib22","first-page":"1116","article-title":"Assessment of cardiovascular risk in older patients with gout initiating febuxostat versus allopurinol: population-based cohort study","volume":"138","author":"Zhang","year":"2018","journal-title":"Circulation (New York, N Y)"},{"key":"10.1016\/j.jfma.2025.05.040_bib23","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.020045","article-title":"Updated assessment of cardiovascular risk in older patients with gout initiating febuxostat versus allopurinol","volume":"10","author":"Pawar","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jfma.2025.05.040_bib24","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00296-022-05222-0","article-title":"Risk of cardiovascular disease associated with febuxostat versus allopurinol use in patients with gout: a retrospective cohort study in Korea","volume":"43","author":"Jeong","year":"2023","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.jfma.2025.05.040_bib25","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/cts.13439","article-title":"Cardiovascular risk of urate-lowering drugs: a study using the national database of Health insurance claims and specific Health checkups of Japan","volume":"16","author":"Sawada","year":"2023","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.jfma.2025.05.040_bib26","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/S0140-6736(20)32234-0","article-title":"Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trial","volume":"396","author":"Mackenzie","year":"2020","journal-title":"The Lancet"},{"key":"10.1016\/j.jfma.2025.05.040_bib27","article-title":"Cardiovascular safety of febuxostat in patients with gout or hyperuricemia: a systematic Review of randomized controlled trials","author":"Ghossan","year":"2023","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.jfma.2025.05.040_bib28","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/hdi.12313","article-title":"Febuxostat improves endothelial function in hemodialysis patients with hyperuricemia: a randomized controlled study","volume":"19","author":"Tsuruta","year":"2015","journal-title":"Hemodial Int"},{"key":"10.1016\/j.jfma.2025.05.040_bib29","first-page":"221","article-title":"Allopurinol improves endothelial dysfunction in chronic heart failure","volume":"106","author":"Farquharson","year":"2002","journal-title":"Circulation (New York, N Y)"},{"key":"10.1016\/j.jfma.2025.05.040_bib30","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1001\/jama.2020.7819","article-title":"Overlap weighting: a propensity score method that mimics attributes of a randomized clinical trial","volume":"323","author":"Thomas","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jfma.2025.05.040_bib31","first-page":"250","article-title":"Addressing extreme propensity scores via the overlap weights","volume":"188","author":"Li","year":"2019","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jfma.2025.05.040_bib32","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.mayocp.2019.03.001","article-title":"Comparing cardiovascular safety of febuxostat and allopurinol in the real world: a population-based cohort study","volume":"94","author":"Su","year":"2019","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jfma.2025.05.040_bib33","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1093\/rheumatology\/kez189","article-title":"Comparative cardiovascular risk of allopurinol versus febuxostat in patients with gout: a nation-wide cohort study","volume":"58","author":"Kang","year":"2019","journal-title":"Rheumatology (Oxf)"},{"key":"10.1016\/j.jfma.2025.05.040_bib34","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1093\/eurheartj\/ehz154","article-title":"Comparative effectiveness of allopurinol and febuxostat for the risk of atrial fibrillation in the elderly: a propensity-matched analysis of Medicare claims data","volume":"40","author":"Singh","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jfma.2025.05.040_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2022.152080","article-title":"Cardiovascular safety associated with febuxostat versus allopurinol among patients with gout: update with accumulated use of febuxostat","volume":"56","author":"Shin","year":"2022","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jfma.2025.05.040_bib36","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/rheumatology\/ken457","article-title":"Febuxostat in the treatment of gout: 5-yr findings of the FOCUS efficacy and safety study","volume":"48","author":"Schumacher","year":"2009","journal-title":"Rheumatology"},{"key":"10.1016\/j.jfma.2025.05.040_bib37","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1751-7133.2011.00262.x","article-title":"Uric acid, heart failure survival, and the impact of xanthine oxidase inhibition","volume":"18","author":"Harzand","year":"2012","journal-title":"Congest Heart Fail"},{"key":"10.1016\/j.jfma.2025.05.040_bib38","first-page":"2619","article-title":"Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies","volume":"105","author":"Doehner","year":"2002","journal-title":"Circulation (New York, N Y)"},{"key":"10.1016\/j.jfma.2025.05.040_bib39","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1536\/ihj.17-391","article-title":"Antiremodeling effect of xanthine oxidase inhibition in a canine model of atrial fibrillation","volume":"59","author":"Yoshizawa","year":"2018","journal-title":"Int Heart J"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664625002700?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664625002700?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T15:20:18Z","timestamp":1779204018000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664625002700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0929664625002700"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2025.05.040","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular outcomes of febuxostat and allopurinol: A long-term Taiwanese nationwide cohort study","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2025.05.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2025, Formosan Medical Association. Published by Elsevier Taiwan LLC. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}